文献速递肥胖与代谢综合征

过量摄入饱和脂肪相比多不饱和脂肪更促进脂肪肝和神经酰胺:一项随机试验

Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

这项双盲随机试验(LIPOGAIN-2)在61名超重或肥胖成人中比较了8周过量摄入饱和脂肪酸(SFA)与多不饱和脂肪酸(PUFA)对肝脏脂肪的影响。结果显示,尽管两组体重增加相似,SFA组肝脏脂肪相对增加50%,并伴随肝酶和致动脉粥样硬化血脂升高,而PUFA组未增加肝脏脂肪或肝酶。SFA增加循环神经酰胺,PUFA则降低神经酰胺,热量限制可逆转SFA的不良代谢效应。

要点

  • 过量摄入SFA比PUFA更显著增加肝脏脂肪和肝酶。
  • SFA升高循环神经酰胺,PUFA降低神经酰胺。
  • PUFA在体重增加时未对血脂产生不良影响。

核心结论

  • 在超重或肥胖成人中,过量摄入SFA显著诱导肝脏脂肪和血清神经酰胺,而PUFA可预防肝脏脂肪积累并降低神经酰胺和高脂血症。

研究设计与样本

  • 双盲随机试验(LIPOGAIN-2),61名超重或肥胖男性和女性,过量摄入SFA或PUFA 8周,随后4周热量限制。

主要发现

  • SFA组体重增加2.31 ± 1.38 kg,PUFA组2.01 ± 1.90 kg,P = 0.50。
  • SFA组肝脏脂肪相对增加50%,并伴随肝酶和致动脉粥样硬化血脂升高。
  • PUFA组未增加肝脏脂肪、肝酶或对血脂产生不良影响。
  • SFA组循环神经酰胺增加,PUFA组降低,变化与肝脏脂肪变化中度相关。
  • SFA对内脏脂肪、胰腺脂肪或全身脂肪积累无差异效应。

临床怎么用

  • 在超重或肥胖个体中,限制SFA摄入可能有助于预防脂肪肝和代谢紊乱。
  • 增加PUFA摄入可能对肝脏脂肪和血脂有保护作用。
  • 热量限制可逆转SFA的不良代谢效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Saturated fatty acid (SFA) vs polyunsaturated fatty acid (PUFA) may promote nonalcoholic fatty liver disease by yet unclear mechanisms. OBJECTIVE: To investigate if overeating SFA- and PUFA-enriched diets lead to differential liver fat accumulation in overweight and obese humans. DESIGN: Double-blind randomized trial (LIPOGAIN-2). Overfeeding SFA vs PUFA for 8 weeks, followed by 4 weeks of caloric restriction. SETTING: General community. PARTICIPANTS: Men and women who are overweight or have obesity (n = 61). INTERVENTION: Muffins, high in either palm (SFA) or sunflower oil (PUFA), were added to the habitual diet. MAIN OUTCOME MEASURES: Lean tissue mass (not reported here). Secondary and exploratory outcomes included liver and ectopic fat depots. RESULTS: By design, body weight gain was similar in SFA (2.31 ± 1.38 kg) and PUFA (2.01 ± 1.90 kg) groups, P = 0.50. SFA markedly induced liver fat content (50% relative increase) along with liver enzymes and atherogenic serum lipids. In contrast, despite similar weight gain, PUFA did not increase liver fat or liver enzymes or cause any adverse effects on blood lipids. SFA had no differential effect on the accumulation of visceral fat, pancreas fat, or total body fat compared with PUFA. SFA consistently increased, whereas PUFA reduced circulating ceramides, changes that were moderately associated with liver fat changes and proposed markers of hepatic lipogenesis. The adverse metabolic effects of SFA were reversed by calorie restriction. CONCLUSIONS: SFA markedly induces liver fat and serum ceramides, whereas dietary PUFA prevents liver fat accumulation and reduces ceramides and hyperlipidemia during excess energy intake and weight gain in overweight individuals.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Rosqvist F, Kullberg J, Ståhlman M, et al. Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial. J Clin Endocrinol Metab. 2019. PMID: 31369090. doi:10.1210/jc.2019-00160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。